secwatch.observer — SEC 8-K summary
======================================

Issuer:     TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
CIK:        0001027838
Form:       8-K
Filed at:   2026-02-17T23:59:59+00:00
Accession:  0001104659-26-016370
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tactile Medical Q4 revenue up 21% to $103.6M; acquires LymphaTech for $6.8M
---------------------------------------------------------------------------

- Q4 2025 revenue $103.6M (+21% YoY); net income $10.6M ($0.46 diluted EPS) vs $9.7M ($0.40) in Q4 2024.
- Full year 2025 revenue $329.5M (+12% YoY); adjusted EBITDA $44.8M ($37.1M in 2024).
- FY2026 guidance: revenue $357-365M (8-11% growth), adjusted EBITDA $49-51M.
- Acquired LymphaTech for $6.8M upfront cash plus contingent milestones; adds 3D scanning for lymphedema.
- Repaid $26.3M term loan; repurchased $26.5M stock at avg $12.36 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1027838/000110465926016370/0001104659-26-016370-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1027838/000110465926016370/tcmd-20260217x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-016370

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer